文献速递其他结缔组织病

新型鼠源自身抗体对干燥综合征的诊断价值:风湿科门诊研究

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-03-02

该研究在风湿科门诊患者中评估三种新型自身抗体(SP-1、PSP、CA-6)对干燥综合征(SjD)的诊断性能,比较SjD与其他自身免疫风湿病、非特异性慢性涎腺炎及对照组的抗体阳性率。结果显示SjD组与其他组间任一新型抗体阳性率无统计学差异(P=0.80),ROC曲线C统计量为0.47(任一阳性)或0.44-0.53(单个抗体),阳性似然比分别为1.04(SjD vs CS)和0.83(SjD vs 对照)。结论认为该血清自身抗体组合不太可能作为SjD的诊断工具。

要点

  • SjD组与其它ARDs、CS或对照组间任一新型自身抗体阳性率无统计学差异(P=0.80)。
  • ROC曲线显示任一阳性NA对SjD vs CS或对照的C统计量为0.47,单个NA为0.44-0.53。
  • 任一阳性NA的阳性似然比:SjD vs CS为1.04,SjD vs 对照为0.83。

核心结论

  • 血清新型自身抗体检测区分SjD与对照、CS或其他ARDs的能力较差,该血清自身抗体组合不太可能作为SjD的诊断试验。

研究设计与样本

  • 研究纳入风湿科门诊确诊的SjD、SLE、RA、SSc、CS患者及健康对照,检测血清抗SP-1、PSP和CA-6抗体,SjD、CS及对照还检测唾液。
  • 筛查468例患者,最终分析444例,包括SjD(n=149)、SLE(n=70)、SSc(n=56)、RA(n=73)、CS(n=31)和对照(n=65)。

主要发现

  • SjD患者血清中一种或多种NA的存在与其它ARDs、CS或对照患者相比无统计学差异(P=0.80)。
  • ROC曲线显示任一阳性NA或任一单个NA对SjD vs CS或对照的判别能力均较差(任一阳性NA C统计量0.47,单个NA范围0.44-0.53)。
  • 任一阳性NA的阳性似然比:SjD vs CS为1.04,SjD vs 对照为0.83。

关键数值与推荐

  • 任一阳性NA对SjD vs CS或对照的ROC曲线C统计量为0.47。
  • 单个NA对SjD vs CS或对照的ROC曲线C统计量范围为0.44-0.53。
  • 任一阳性NA的阳性似然比:SjD vs CS为1.04,SjD vs 对照为0.83。

临床怎么用

  • 该血清新型自身抗体组合对SjD的诊断区分能力较差,不太可能作为SjD的诊断试验。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls. METHODS: We identified rheumatology outpatients with confirmed SjD, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), CS, and healthy controls. Participants underwent serum testing for antibodies to salivary gland protein 1 (SP-1), parotid secretory protein, and carbonic anhydrase-6 (CA-6). Participants with SjD, CS, and controls also underwent testing of saliva. Receiver operating characteristic (ROC) curve C-statistics along with sensitivity, specificity, positive, and negative likelihood ratios were calculated for each serum autoantibody for SjD vs CS or controls. RESULTS: Among the 468 patients screened, 444 were analyzed, including cohorts with SjD (n = 149), SLE (n = 70), SSc (n = 56), RA (n = 73), CS (n = 31), and control patients (n = 65). There was no statistical difference (P = 0.80) in the presence of one or more NA in the serum of patients with SjD compared with participants with other ARDs, CS, or control patients. ROC curves demonstrated poor discriminative ability for SjD versus CS or control patients for any positive NA (0.47) or any individual NA (range 0.44-0.53). The positive likelihood ratio for having any positive novel autoantibody was 1.04 and 0.83 for SjD vs CS or control patients, respectively. CONCLUSION: Testing serum for NA demonstrated a poor ability to distinguish patients with SjD from control patients or those with CS or other ARDs. This serum autoantibody panel is not likely to be useful as a diagnostic test for SjD.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Johr CR, George MD, Bunya VY, et al. Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting. Arthritis Care Res (Hoboken). 2026. PMID: 41312674. doi:10.1002/acr.70005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。